Sphere Bio (formerly Sphere Fluidics)
Entry
2021
Hold
4yr
Exit
2025
Who owns Sphere Bio (formerly Sphere Fluidics)?
Sphere Bio (formerly Sphere Fluidics) was owned by Sofinnova Partners through Sofinnova Crossover Fund I (2018 vintage) from 2021 to 2025, exited via Trade Sale.
Buyer identity available on Pro.
Hand-verified · updated 2026-06-11
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2025
More from Sofinnova Crossover Fund I
Other portfolio companies in the same fund.
Sweden
DenmarkMore PE-backed in MedTech
Comparable medtech deals from other GPs.
Optos
Exited 2015
Amadeus Capital Partners
UK
UKto
Axomove
Active
Go Capital
France· 2026
France· 2026Bioliberty
Active
Scottish National Investment BankUK· 2026
UK· 2026CertHub
Active
Cusp Capital Partners
Germany· 2026
Germany· 2026Clee Medical
Active
High-Tech Gruenderfonds (HTGF)
Switzerland· 2026
Switzerland· 2026CollimateHealth
Active
Caesar Ventures ManagementGermany· 2026
Germany· 2026Track Sphere Bio (formerly Sphere Fluidics)
Save this record to your watchlist and pick up your research where you left off. No spam.
Get the full record on Sphere Bio (formerly Sphere Fluidics).
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
Already a member? Sign in
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue